Piper Sandler Adjusts Price Target on Stryker
Piper Sandler has updated its price target for Stryker Corporation, raising it to $350 from $325.
Stocks · News reference
Block To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Monday
Analysts raised targets for Magnite, Airbnb and Choice Hotels; cut targets for Unusual Machines, DraftKings, PDD and TeraWulf. DKNG and PDD downgraded.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Stryker Announces Intention to Nominate Jim Davis to Board of Directors
Stryker Corporation has nominated Jim Davis, the Chairman, CEO, and President of Quest Diagnostics, for election to its board of directors effective January 1, 2027.
Jefferies Maintains Buy on Airbnb, Raises Price Target to $230
8-K filing — STRYKER CORP (SYK)
Filed: 2026-11-09 AccNo: 0001193125-26-453635 Size: 247 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
JP Morgan Downgrades DraftKings to Neutral, Lowers Price Target to $21
Celcuity Announces FDA Acceptance of sNDA for REVTORPYK™ (gedatolisib)
The FDA has accepted Celcuity's supplemental New Drug Application (sNDA) for REVTORPYK™ (gedatolisib) to treat HR+/HER2-, PIK3CA-mutant locally advanced or metastatic breast cancer.